Skip to main content

and
  1. Article

    Open Access

    Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model

    We recently reported that poly-arginine peptides have neuroprotective properties both in vitro and in vivo. In cultured cortical neurons exposed to glutamic acid excitotoxicity, we demonstrated that neuroprote...

    Diego Milani, Vince W. Clark, Jane L. Cross, Ryan S. Anderton in BMC Neuroscience (2016)

  2. No Access

    Article

    Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine–Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats

    We have demonstrated that arginine-rich and poly-arginine peptides possess potent neuroprotective properties with arginine content and peptide positive charge being particularly critical for neuroprotective ef...

    Bruno P. Meloni, Diego Milani, Jane L. Cross, Vince W. Clark in NeuroMolecular Medicine (2017)

  3. Article

    Open Access

    Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat

    We examined the neuroprotective efficacy of the poly-arginine peptide R18 and its D-enantiomer R18D in a perinatal hypoxic-ischaemic (HI) model in P7 Sprague-Dawley rats. R18 and R18D peptides were administere...

    Adam B. Edwards, Jane L. Cross, Ryan S. Anderton, Neville W. Knuckey in Molecular Brain (2018)